Arginine

Arginine

SCHEMBL1697257

CC(C)C[C@H](N)C(=O)O.N=C(N)NCCC[C@H](N)C(=O)O.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PRCP P42785 2/20 0.38
SLC7A5 Q01650 1/20 0.38
NPY4R P50391 6/20 0.35
NPY1R P25929 5/20 0.35
NPY2R P49146 4/20 0.35
NPY5R Q15761 4/20 0.35
OTC P00480 1/20 0.34
ANPEP P15144 2/20 0.34
RNPEP Q9H4A4 2/20 0.34
DNPEP Q9ULA0 1/20 0.34
NOS2 P35228 3/20 0.33
NOS3 P29474 2/20 0.33
NOS1 P29475 2/20 0.33
DDAH1 O94760 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL28419523 1.00 PRCP (0.38) PRCPSLC7A5NPY4RNPY1RNPY2R
Arginine SCHEMBL2459501 0.98 PRCP (0.37) PRCPSLC7A5NPY4RNPY1RNPY2R
Arginine SCHEMBL8628358 0.96 PRCP (0.35) PRCPSLC7A5NPY4RNPY1RNPY2R
Arginine SCHEMBL9480236 0.96 PRCP (0.35) PRCPSLC7A5NPY4RNPY1RNPY2R
Arginine SCHEMBL28552748 0.96 PRCP (0.35) PRCPSLC7A5NPY4RNPY1RNPY2R
Arginine SCHEMBL27883095 0.96 PRCP (0.35) PRCPSLC7A5NPY4RNPY1RNPY2R
Arginine SCHEMBL29255555 0.96 PRCP (0.35) PRCPSLC7A5NPY4RNPY1RNPY2R
Arginine SCHEMBL29157307 0.95 PRCP (0.35) PRCPSLC7A5NPY4RNPY1RNPY2R
Arginine SCHEMBL4278540 0.95 PRCP (0.35) PRCPSLC7A5NPY4RNPY1RNPY2R
Arginine SCHEMBL1551248 0.93 PRCP (0.35) PRCPSLC7A5NPY4RNPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140315278-A1 SPORE SURFACE DISPLAYS OF BIOACTIVE MOLECULES DSM IP ASSETS B.V. (NL) 2014-10-23 US disclosed
US-20130216653-A1 SPORE SURFACE DISPLAY OF BIOACTIVE MOLECULES DSM IP ASSETS B.V. (NL) 2013-08-22 US disclosed
EP-2588614-A1 SPORE SURFACE DISPLAY OF BIOACTIVE MOLECULES DSM IP Assets B.V. (NL) 2013-05-08 EP disclosed
WO-2012001000-A1 SPORE SURFACE DISPLAY OF BIOACTIVE MOLECULES DSM IP ASSETS B.V. (NL) 2012-01-05 WO disclosed
US-20100055244-A1 SPORE SURFACE DISPLAYS OF BIOACTIVE MOLECULES DSM IP ASSETS B.V. (NL) 2010-03-04 US disclosed
EP-2049669-A2 SPORE SURFACE DISPLAYS OF BIOACTIVE MOLECULES DSMIP Assets B.V. (NL) 2009-04-22 EP disclosed
WO-2008017483-A2 SPORE SURFACE DISPLAYS OF BIOACTIVE MOLECULES DSM IP ASSETS B.V. (NL) 2008-02-14 WO disclosed
EP-0873404-B1 ANGIOTENSIN CONVERTING ENZYME INHIBITORS NONG SIM CO LTD (KR) 2003-04-16 EP disclosed
US-6232438-B1 TRIPEPTIDE HISTIDINE-HISTIDINE-LEUCINE; DERIVED FROM FERMENTED SOYBEAN PASTE FOR CONTROLLING HYPERTENSION; EXHIBITS SIMILAR OR HIGHER ACTIVITIES NONG SHIM CO., LTD. (KR) 2001-05-15 US disclosed
EP-0873404-A1 ANGIOTENSIN CONVERTING ENZYME INHIBITORS Nong Shim Co., Ltd. (KR) 1998-10-28 EP disclosed
WO-1997025418-A1 ANGIOTENSIN CONVERTING ENZYME INHIBITORS NONG SHIM CO., LTD. (KR) 1997-07-17 WO disclosed